Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-1.51	32.64	33.14
Graham Fair Price	75.49	4.44	2.53
PEG	-85.46	0.08	-0.55
Price/Book	10.94	4.89	4.41
Price/Cash Flow	569.40	179.97	26.88
Prices/Earnings	-61.51	16.17	42.02
Price/Sales	25.80	9.19	7.31
Price/FCF	569.40	179.97	26.88
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	3.85	0.74	0.71
Operating Margin	106.14	0.27	0.13
ROA	201.38	0.02	< 0.005
ROE	0.03	0.08	188.21
ROIC	0.04	0.05	37.37
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.01	-0.14	89.91
Dividends QOQ	< 0.005	< 0.005	115.57
EBIT QOQ	-0.46	0.88	92.29
EPS QOQ	-0.76	2.01	164.74
FCF QOQ	0.28	-0.83	200.27
Revenue QOQ	-0.01	-0.09	-633.82
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	211.64	264.94	25.18
Days Sales Outstanding (DSO)	82.75	89.12	7.70
Inventory Turnover	0.43	0.34	-20.12
Debt/Capitalization	0.56	0.56	0.44
Quick Ratio	0.60	0.57	-3.96
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3.29	3.40	3.37
Cash	1.28	1.01	-21.22
Capex	-0.19	-0.14	28.32
Free Cash Flow	0.54	0.09	-82.87
Revenue	1.99	1.81	-8.84
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.88	0.87	-2.04
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.76	5.92	-12.51
Naive Interpretation	Member

06 - Financial Health · Bad

Rating